Alembic Pharmaceuticals Limited
ICICI Prudential Mutual Fund increased its stake in Alembic Pharmaceuticals from 1.12% to 1.38%, buying 505,125 shares for ₹42.0 Cr at ₹831.05 apiece.
A pharmaceutical company engaged in the development, manufacturing, and marketing of formulations and active pharmaceutical ingredients for domestic and international markets. Alembic Pharma operates three dedicated research and development centers alongside five manufacturing facilities to support its operations across multiple therapeutic areas. The company focuses on producing generic and specialized pharmaceutical products while maintaining vertically integrated operations.
India's second-largest AMC by AUM with over Rs 9 lakh crore managed across 80+ schemes. Joint venture between ICICI Bank and Prudential plc. CIO S. Naren is one of India's most recognised value investors, known for contrarian macro calls and rotating across market caps well ahead of consensus. ICICI Pru's quarterly portfolio disclosures are among the most closely watched in the industry.